AIC
BLUE

Ameritas Investment Company’s bluebird bio BLUE Stock Holding History

Ameritas Investment Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$513 – 879
2021
Q1 		$513 Buy
+1
New +$492 ﹤0.01% 2171
2020
Q2 		– Sell
-4
Closed -$2K – 467
2020
Q1 		$2K Buy
+4
New +$3.9K ﹤0.01% 1551

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Ameritas Investment Company's BLUE Position: Q2 2021 in Review

Ameritas Investment Company sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1 share — an estimated $513 sold.

Ameritas Investment Company first reported a position in BLUE in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Ameritas Investment Company reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 1 bluebird bio share in Q2 2021, an estimated $513.
  • Ameritas Investment Company first reported a position in bluebird bio in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's bluebird bio position peaked at $2K in Q1 2020.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.